Validation of the Functional Assessment of Cancer Therapy - Lymphoma (FACT-LYM) in Patients with Relapsed/Refractory Mantle Cell Lymphoma.

被引:0
|
作者
Carter, Gebra Cuyun [1 ]
Liepa, Astra M. [1 ]
Zimmermann, Anna Hayden [2 ]
Morschhauser, Franck [3 ]
机构
[1] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Stat, Indianapolis, IN 46285 USA
[3] Ctr Hosp Univ, Lille, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:828 / 828
页数:1
相关论文
共 50 条
  • [31] SALVAGE TREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MANTLE CELL LYMPHOMA
    Zaja, F.
    De Luca, S.
    Vitolo, U.
    Orsucci, L.
    Levis, A.
    Salvi, F.
    Gargantini, L.
    Ravelli, E.
    Tucci, A.
    Bottelli, C.
    Balzarotti, M.
    Santoro, A.
    Brusamolino, E.
    Bonfichi, M.
    Di Rocco, A.
    Stelitano, C.
    Baldini, L.
    Pileri, S.
    Volpetti, S.
    Saccona, F.
    Ciccone, G.
    Ferranti, A.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 115 - 115
  • [32] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Fukuhara, Noriko
    Kitano, Toshiyuki
    Ishikawa, Takayuki
    Shibayama, Hirohiko
    Choi, Ilseung
    Hatake, Kiyohiko
    Uchida, Toshiki
    Nishikori, Momoko
    Kinoshita, Tomohiro
    Matsuno, Yoshihiro
    Nishikawa, Tomoaki
    Takahara, Satoko
    Tobinai, Kensei
    CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
  • [33] Validation of the Mantle Cell Lymphoma Prognostic Index (MIPI): A Valuable Tool for Risk Stratification in Mantle Cell Lymphoma.
    Smith, Stephen Douglas
    Hsi, Eric D.
    Bolwell, Brian J.
    Maggiotto, Amanda
    Effinger, Meagan
    Sweetenham, John William
    BLOOD, 2009, 114 (22) : 1058 - 1059
  • [34] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Kim, Sung-Won
    Izutsu, Koji
    Iwato, Kouji
    Fukuda, Takahiro
    Uchida, Naoyuki
    Amano, Itsuto
    Nakazawa, Hideyuki
    Kuroda, Junya
    Hashimoto, Hisako
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1445 - 1452
  • [35] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Sung-Won Kim
    Koji Izutsu
    Kouji Iwato
    Takahiro Fukuda
    Naoyuki Uchida
    Itsuto Amano
    Hideyuki Nakazawa
    Junya Kuroda
    Hisako Hashimoto
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2018, 97 : 1445 - 1452
  • [36] Rituximab Plus Gemcitabine and Oxaliplatin as Salvage Therapy In Patients with Relapsed/Refractory Mantle-Cell Lymphoma
    Gironella, Mercedes
    Lopez, Andres
    Pau, Abrisqueta
    Anny, Jaramillo
    Noelia, Purroy
    Bosch, Francesc
    BLOOD, 2010, 116 (21) : 1165 - 1165
  • [37] Rituximab Plus Gemcitabine and Oxaliplatin As Salvage Therapy in Patients with Relapsed/Refractory Mantle-Cell Lymphoma
    Gironella, Mercedes
    Lopez, Andres
    Merchan, Brayan
    Abrisqueta, Pau
    Jaramillo, Anny
    Bosch, Francesc
    BLOOD, 2012, 120 (21)
  • [38] Current strategies in mantle cell lymphoma. Conventional therapy
    Dreyling, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 48
  • [39] Multimodal dose dense therapy for mantle cell lymphoma.
    Wanko, SO
    Gocherman, JP
    Moore, JO
    Decastro, C
    Prosnitz, R
    Gasparetto, C
    Chute, J
    Horowitz, M
    Ashley, M
    Emily, E
    Patty, D
    Nelson, CJ
    Rizzieri, DA
    BLOOD, 2004, 104 (11) : 329A - 330A
  • [40] Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective
    Desai, Madhav
    Newberry, Kate
    Ou, Zhishuo
    Wang, Michael
    Zhang, Liang
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (03) : 91 - 101